The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Islet cell autoantigens in insulin-dependent diabetes
Open accessAbstract
A burgeoning number of antigenic targets of the islet cell autoimmunity in IDD have been identified, and more can be anticipated through improved methods for their identification. The challenge for those investigating the pathogenesis of IDD will be to assign the relative importance of these antigens to the development of the disease, and to resolve whether there is a dominant primary immunologic event that is followed by a series of secondary immunizations to a variety of normally sequestered islet cell antigens in the sequence of pathogenic events that culminate in IDD. One interesting observation that may have potential pathogenic implications is the observation that of all islet cell autoantigens described, only two (i.e., 64 kD/GAD, 38 kD) are reactive in their native configurations, implying that recognition of conformational epitopes is most important. This property argues for primary immunizing agents rather than secondary ones after release of denatured antigens and antigenic recognition through their epitopes. Given the complex and multiple physiological functions of islet cells and the continuous variation in their activity, it is reasonable to speculate that the speed of the progression to IDD could vary between individuals with respect to their insulin needs and the relative activities of their islets. Activated islets may express autoantigens that have only limited expression in quiescent islets. The often times striking variation in the severity of insulitis seen in different islets of a single pancreas may be explained by the level of activity of individual islets. Furthermore, disparity in HLA-DR/DQ associations with disease may involve differences in the immunological recognition of autoantigens. Whereas there is still much to learn, it is clear that disease predictability and disease intervention studies have been enhanced through the identification of the islet cell autoantigens in IDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baekkeskov, S., Aanstoot, H.-J., Christgai, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., & Camilli, P.-D. (1990) · Nature · doi:10.1038/347151a0 · Cited by 1,964
ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469
Insulin antibodies in insulin-dependent diabetics before insulin treatment
Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science · doi:10.1126/science.6362005 · Cited by 1,078
Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man Syndrome
Solimena, M., Folli, F. B., Aparisi, R., Pozza, G., & Camilli, P. V. D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222202 · Cited by 623
Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Zhang, Z. J., Davidson, L., Eisenbarth, G. S., & Weiner, H. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10252 · Cited by 556
Bækkeskov, S., Nielsen, J. H., Marner, B., Bilde, T., Ludvigsson, J., & Lernmark, Å. (1982) · Nature · doi:10.1038/298167a0 · Cited by 530
Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus
Kaufman, D. L., Erlander, M. G., Clare-Salzler, M., Atkinson, M. A., Maclaren, N. K., & Tobin, A. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115573 · Cited by 490
Self-citationElias, D., Markovits, D., Reshef, T., van der Zee, R., & Cohen, I. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1576 · Cited by 441
Davidson, H. W., Rhodes, C. J., & Hutton, J. C. (1988) · Nature · doi:10.1038/333093a0 · Cited by 406
A Bovine Albumin Peptide as a Possible Trigger of Insulin-Dependent Diabetes Mellitus
Karjalainen, J., Martin, J. M., Knip, M., Ilonen, J., Robinson, B. H., Savilahti, E., Akerblom, H. K., & Dosch, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270502 · Cited by 386
Flagged first, then by citations
Research works printed but not linked: 2
- Bu, D. F., M. G. Erlander, B. C. Hitz, N. J. K. Tillakaratne, D. L. Kauf- man, C. B. Wagner-McPherson, G. A. Evans, and A. J. Tobin. 1993. Two human glutamate decarboxylases, GAD 65 and GAD 67, are each encoded by a single gene. Proc. NatL. Acad. Sci. USA. In press.
- Zhang, Z. J., L. Davidsen, G. S. Eisenbarth, H. L. Weiner, and R. S. Weiner. 1991. Suppression ofdiabetes in non obese diabetic mice by oral adminis- tration of porcine insulin. Proc. Natl. Acad. Sci. USA 88:10252-10256.
Cited by
Sorted by citations
Items 101–128 of 128
Antigenic determinants in type 1 diabetes mellitus:
Dotta, F., & Mario, U. D. (1996) · Apmis · doi:10.1111/j.1699-0463.1996.tb04941.x · Cited by 6
Type I Insulin-Dependent Diabetes Mellitus: a Model for Autoimmune Polygenic Disorders
Winter, W. E. (1996) · Advances in Dental Research · doi:10.1177/08959374960100011701 · Cited by 4
Villalba, A., Iacono, R. F., Valdez, S. N., & Poskus, E. (2008) · Autoimmunity · doi:10.1080/08916930701783338 · Cited by 5
Autoimmunity and Immunotherapy of Type 1 Diabetes
Aribi, M. (2011) · InTech eBooks · doi:10.5772/20674 · Cited by 6
The use of islet autoantibody markers in the prediction of autoimmune type 1 diabetes
Winter, W. E. (1999) · Clinical Immunology Newsletter · doi:10.1016/s0197-1859(00)80037-0 · Cited by 3
Cooper, G. J. S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_14 · Cited by 2
Autoantigens in type 1 diabetes mellitus
Dotta, F., Anastasi, E., Tiberti, C., & Mario, U. D. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347744 · Cited by 2
Drews, G. (1996) · Springer eBooks · doi:10.1007/978-3-642-60946-6_67 · Cited by 2
Immunology of gestational diabetes mellitus
de Leiva, A., Mauricio, D., & Corcoy, R. (2008) · Series in maternal-fetal medicine · doi:10.3109/9781439802007.013 · Cited by 1
Gomaa, S., Nassef, M., & Hafez, A. (2024) · Endocrine · doi:10.1007/s12020-024-03929-7 · Cited by 3
Organ-Specific Autoimmune Diseases
Bylund, D. J., & Nakamura, R. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0974-2.00053-1 · Cited by 1
Lundgren, V. (2013) · Työväentutkimus Vuosikirja · Cited by 1
Type I Diabetes Mellitus (Insulin‐Dependent Diabetes Mellitus)
Rizza, R. A., Jensen, M. D., & Nair, K. S. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070236 · Cited by 1
Immunology of Type 1 Diabetes Mellitus
Pietropaolo, M., Zhang, Y., & Trucco, M. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0507-5_2 · Cited by 1
Nagai, T., Imamura, M., & Mori, M. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.299 · Cited by 1
Role of IA-2 antibodies in clinical and preclinical type 1 diabetes
Savola, K. (2000) · Cited by 1
Plesner, A., & Lernmark, Å. (1998) · Springer eBooks · doi:10.1007/978-94-011-5044-6_7 · Cited by 1
The effects of interleukin-22 and -17 on beta-cell destruction in vitro
Kilpeläinen, N. (2014) · Työväentutkimus Vuosikirja
Dietary insulin and the gut immune system in type 1 diabetes
Paronen, J. (2001) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Autoimmune Antigen Presentation Mechanisms
Dwyer, E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1610-0_7
Epidemiology and pathogenesis of type 1 diabetes
Parthasarathy, S., & Choudhary, P. (2015) · doi:10.1002/9781119121725.ch7
Molecular Bases of Endocrinopathies
Bolander, F. F. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-111231-8.50022-0
英二, 川., Sera, Y., 藤田, 成., 安部, 幸., 山内, 三., 尾崎, 方., 宮副, 治., 山川, 賢., Uotani, S., 瀧野, 博., et al. (2000) · 糖尿病 · doi:10.11213/tonyobyo1958.43.1051
Dotta, F., Previti, M., Lenti, L., Dionisi, S., Casetta, B., D’Erme, M., Eisenbarth, G. S., & Mario, U. D. (1995)
Ontogeny of the Human Pancreas
Proshchina, A. E., Krivova, Y. S., Gurevich, L. E., Barabanov, V. M., Otlyga, D., Voronkova, I. А., & Saveliev, S. V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84515
Ali, B., Omar, S. M. A., N. H., & Osman, T. (2020) · Minia Journal of Medical Research · doi:10.21608/mjmr.2022.217626
Autoantibodies against islet cellantigens: Current diagnostic possibilities
Ochocińska, A., Wysocka‐Mincewicz, M., & Cukrowská, B. (2022) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0016.3189
Cytokines and Human Type 1 Diabetes
Kent, S. C., Viglietta, V., & Hafler, D. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-129-9_12
Metadata
- Authors
- Atkinson, M. A., & Maclaren, N. K.
- Affiliations
- University of Florida (US)
- ORCID
- Atkinson, M A
- Venue
- Journal of Clinical Investigation
- Published
- 1993-10-01
- Volume
- 92
- Issue
- 4
- Pages
- 1608-1616
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC288318
- OpenAlex
- W2141405570
- Cited by
- 129
- References
- 64
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 3
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, type 1 diabetes pathogenesis, islet autoimmunity, glutamic acid decarboxylase, conformational epitopes, insulitis, disease prediction
- MeSH terms
- Autoantigens, Carboxypeptidases, Diabetes Mellitus, Type 1, Glutamate Decarboxylase, Heat-Shock Proteins, Humans, Islets of Langerhans, Monosaccharide Transport Proteins, Proinsulin, Serum Albumin, Bovine, T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
